Article Listing - RUSSIA INSULIN DEBT: 12 MILLION AT RISK

DIPENTUM COMPARED WITH ASACOL

1 June 1992

Kabi Pharmacia's aminosalicylate product Dipentum (olsalazine sodium) has been found to be clearly superior to Tillotts' Asacol (mesalazine) in terms...

FRESENIUS POST 53% INCREASE IN PROFITS

25 May 1992

German pharmaceutical and medical technology group, Fresenius, posted net profits of 15.9 million Deutschemarks ($9.6 million), up 53% in 1991....

ICI AUSTRALIA RESULTS

25 May 1992

- ICI Australia Ltd reported a 27% rise in its net profits to A$30.4 million ($22.9 million) on turnover...

HOECHST-ROUSSEL TO EXTEND LOPROX RANGE

25 May 1992

- Hoechst-Roussel is to develop additional products based on its antifungal agent Loprox (ciclo-pirox olamine). These will include a gel...

RHONE-POULENC EARNINGS SURGE 78%

25 May 1992

First-quarter 1992 net earnings for France's Rhone-Poulenc jumped 78% to 769 million francs ($143.5 million, helped by lower financial char-ges,...

ARES-SERONO 1st QTR SALES UP 25%

25 May 1992

Swiss human fertility and pharmaceutical concern, Ares-Serono, made sales in the first quarter of 1992 of $198 million, up 15.5%...

STOCK MARKET COMMENTARY: EUROPE

25 May 1992

EUROPE: saw stock markets close the reporting period on small declines, first in sympathy with Wall Street weakness and then...

SMITHKLINE BEECHAM COMPETES GLOBALLY

25 May 1992

The scale and shape of SmithKline Beecham is no accident, Henry Wendt, company chairman, told shareholders at the annual general...

BRAZIL STALLS ON PATENT REFORM

25 May 1992

Brazil is delaying passing its promised patent protection law, despite US pressure for faster action. The Chamber of Deputies has...

SANDOZ PHARMA DIV 1991 PROGRESS

25 May 1992

Switzerland's Sandoz reported total sales up 8.7% at 13.44 billion Swiss francs for 1991 (Marketletter April 6), and its annual...

Showing 94011-94020 of 95582 articles